Literature DB >> 25080147

Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory.

Pingguang Lei1, Guanghe Lei, Jianjun Tian, Zengfen Zhou, Miao Zhao, Chonghua Wan.   

Abstract

PURPOSE: This paper is aimed to develop the irritable bowel syndrome (IBS) scale of the system of Quality of Life Instruments for Chronic Diseases (QLICD-IBS) by the modular approach and validate it by both classical test theory and generalizability theory.
METHODS: The QLICD-IBS was developed based on programmed decision procedures with multiple nominal and focus group discussions, in-depth interview, and quantitative statistical procedures. One hundred twelve inpatients with IBS were used to provide the data measuring QOL three times before and after treatments. The psychometric properties of the scale were evaluated with respect to validity, reliability, and responsiveness employing correlation analysis, factor analyses, multi-trait scaling analysis, t tests and also G studies and D studies of generalizability theory analysis.
RESULTS: Multi-trait scaling analysis, correlation, and factor analyses confirmed good construct validity and criterion-related validity when using SF-36 as a criterion. Test-retest reliability coefficients (Pearson r and intra-class correlation (ICC)) for the overall score and all domains were higher than 0.80; the internal consistency α for all domains at two measurements were higher than 0.70 except for the social domain (0.55 and 0.67, respectively). The overall score and scores for all domains/facets had statistically significant changes after treatments with moderate or higher effect size standardized response mean (SRM) ranging from 0.72 to 1.02 at domain levels. G coefficients and index of dependability (Ф coefficients) confirmed the reliability of the scale further with more exact variance components.
CONCLUSIONS: The QLICD-IBS has good validity, reliability, responsiveness, and some highlights and can be used as the quality of life instrument for patients with IBS.

Entities:  

Mesh:

Year:  2014        PMID: 25080147     DOI: 10.1007/s00384-014-1976-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  27 in total

Review 1.  Methods for assessing responsiveness: a critical review and recommendations.

Authors:  J A Husted; R J Cook; V T Farewell; D D Gladman
Journal:  J Clin Epidemiol       Date:  2000-05       Impact factor: 6.437

2.  On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.

Authors:  C B Terwee; F W Dekker; W M Wiersinga; M F Prummel; P M M Bossuyt
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

3.  The hypertension scale of the system of Quality of Life Instruments for Chronic Diseases, QLICD-HY: a development and validation study.

Authors:  Chonghua Wan; Runsheng Jiang; Xin M Tu; Wan Tang; Jiahua Pan; Ruixue Yang; Xiaomei Li; Zheng Yang; Xiaoqing Zhang
Journal:  Int J Nurs Stud       Date:  2011-12-20       Impact factor: 5.837

Review 4.  Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia.

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Gastroenterol Hepatol       Date:  2007-01       Impact factor: 4.029

5.  The IBS-36: a new quality of life measure for irritable bowel syndrome.

Authors:  Dianne Groll; Stephen J Vanner; William T Depew; Laurington R DaCosta; Jerome B Simon; Aubrey Groll; Nancy Roblin; William G Paterson
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

6.  Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.

Authors:  D L Patrick; D A Drossman; I O Frederick; J DiCesare; K L Puder
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

7.  Validation of a specific quality of life questionnaire for functional digestive disorders.

Authors:  O Chassany; P Marquis; B Scherrer; N W Read; T Finger; J F Bergmann; B Fraitag; J Geneve; C Caulin
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

8.  Prevalence, comorbidity and impact of irritable bowel syndrome in Norway.

Authors:  Per Olav Vandvik; Stian Lydersen; Per G Farup
Journal:  Scand J Gastroenterol       Date:  2006-06       Impact factor: 2.423

9.  A generalizability theory analysis of group process ratings in the treatment of cocaine dependence.

Authors:  Paul Crits-Christoph; Jennifer Johnson; Robert Gallop; Mary Beth Connolly Gibbons; Sarah Ring-Kurtz; Jessica L Hamilton; Xin Tu
Journal:  Psychother Res       Date:  2011-05

10.  Reliability of observers' subjective impressions of families: a generalizability theory approach.

Authors:  Bent Stora; Knut A Hagtvet; Sonja Heyerdahl
Journal:  Psychother Res       Date:  2012-10-15
View more
  5 in total

Review 1.  A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.

Authors:  Jiyeon Lee; Eun-Hyun Lee; Seung Hei Moon
Journal:  Qual Life Res       Date:  2016-09-29       Impact factor: 4.147

2.  Reliability analysis of the Chinese version of the Functional Assessment of Cancer Therapy - Leukemia (FACT-Leu) scale based on multivariate generalizability theory.

Authors:  Qiong Meng; Zheng Yang; Yang Wu; Yuanyuan Xiao; Xuezhong Gu; Meixia Zhang; Chonghua Wan; Xiaosong Li
Journal:  Health Qual Life Outcomes       Date:  2017-05-04       Impact factor: 3.186

3.  Development and validation of the peptic ulcer scale under the system of quality of life instruments for chronic diseases based on classical test theory and generalizability theory.

Authors:  Chonghua Wan; Ying Chen; Li Gao; Qingqing Zhang; Peng Quan; Xiaoyuan Sun
Journal:  BMC Gastroenterol       Date:  2020-12-14       Impact factor: 3.067

4.  Development and Validation of the Chronic Gastritis Scale Under the System of Quality of Life Instruments for Chronic Diseases QLICD-CG Based on Classical Test Theory and Generalizability Theory.

Authors:  Chonghua Wan; Ying Chen; Li Gao; Qingqing Zhang; Wu Li; Peng Quan
Journal:  J Clin Gastroenterol       Date:  2022-02-01       Impact factor: 3.174

5.  Development and validation of the pulmonary tuberculosis scale of the system of Quality of Life Instruments for Chronic Diseases (QLICD-PT).

Authors:  Yanchun Sun; Zheng Yang; Chonghua Wan; Chuanzhi Xu; Liuping Chen; Lin Xu; Xiaoqing Zhang; Fei Yan
Journal:  Health Qual Life Outcomes       Date:  2018-07-11       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.